Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.100
+0.230 (12.30%)
At close: Jun 26, 2026, 4:00 PM EDT
2.103
+0.003 (0.15%)
Pre-market: Jun 29, 2026, 5:59 AM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $244.77 million as of June 29, 2026. Its market cap has increased by 37.75% in one year.
Market Cap
244.77M
Enterprise Value
146.74M
1-Year Change
37.75%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $244.77M, an increase of 94.11%. That is a compound annual growth rate of 5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 244.80M | 115.87% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 262.70M |
| Nautilus Biotechnology | 254.16M |
| AC Immune | 253.95M |
| Orchestra BioMed Holdings | 253.89M |
| Fulcrum Therapeutics | 253.21M |
| Foghorn Therapeutics | 247.77M |
| Anavex Life Sciences | 242.80M |
| Sol-Gel Technologies | 240.27M |